Live Breaking News & Updates on Immunoglobulin E

Stay updated with breaking news from Immunoglobulin e. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Atopic Dermatitis Treatment Equally Effective in Extrinsic, Intrinsic Subtypes

Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.
....

Dermatology Clinic Of The Turin University Hospital , Dermatology Clinic , Turin University Hospital , Severity Index , Dermatology Life Quality Index , Intrinsic Atopic Dermatitis , Extrinsic Atopic Dermatitis , Immunoglobulin E ,

Prurigo Nodularis Improves Following Treatment With Dupilumab

Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the monoclonal antibody for the chronic inflammatory skin condition.

....

Global Assessment , Skin Lesions , Prurigo Nodularis , Immunoglobulin E ,